Expansion of facilities

The Electrospinning Company is fitting out a new facility in the brand new Zephyr building on Harwell Campus, near Oxford, in responding to a growing demand for electrospun biomaterials in regenerative medical devices. The new larger facility will include modular, state-of-the art cleanrooms for manufacturing, a dedicated design and development laboratory and offices. “This expansion will allow… Read more »

Melt electrospinning arrives at The Electrospinning Company

Part of the BONE project, The Electrospinning Company will be playing a crucial role in translating academic findings using melt electrospinning into clinical-grade products. We are extremely excited to have finally received our melt electrospinning device, work together with our BONE partners towards novel medical devices and expanding our expertise in electrospinning. the Electrospinning Team

ISO 13485:2016 QMS recertification

The Electrospinning Company has updated its Quality Management System to the new ISO 13485:2016 standard for the design, development, manufacture and supply of electrospun polymer scaffolds, and has been re-certified for a further three years. The ISO13485 standard has been updated from 13485:2003 to 13485:2016 to keep up with changes in the medical device industry… Read more »

Biomaterials Risk Management BIORIMA H2020 grant

The Electrospinning Company is a partner in the EU funded H2020 Research and Innovation action BIORIMA (Biomaterial Risk Management). The project aims to develop an integrated risk management framework for nano-biomaterials used in advanced therapeutic medicinal products and medical devices. The BIORIMA risk management framework is a structure upon which the validated tools and methods… Read more »

BioBeat BioBusiness 2017

Ann Kramer, CEO of The Electrospinning Company is named as one of 50 female leaders in healthcare business in the UK in a report produced by BioBeat, 50 Movers and Shakers in BioBusiness 2017 , which emphasises how diversity of thinking is critical to the success of the sector in the UK. The 50 Movers and… Read more »

Stem cell culture in coated scaffolds

A simple 3-D culture system, made of electrospun polycaprolactone (PCL) fibers and coated with defined extracellular proteins that occur naturally in the stem cell niche, allowed dispersed attachment and culture of human pluripotent stem cells devoid of cell aggregation. A publication from The Royal Institute of Technology (KTH), Stockholm describes how PCL fiber scaffolds coated… Read more »

Stewart White appointed NED

The Electrospinning Company has strengthened its Board with the appointment of Dr Stewart White as non-executive director. Stewart was previously CEO of two life science AIM-quoted companies including Collagen Solutions Ltd., and is currently Chairman of Mikota Ltd and non-executive director with Taragenyx.  Stewart has international executive experience in commercial and product development, GMP manufacturing of… Read more »

KTP award for smart biomaterial development

The Electrospinning Company and the University of Nottingham have been awarded a Knowledge Transfer Partnership project to develop thermo-responsive scaffolds for 3D cell culture. The Electrospinning Company has a range of materials in development for use in 3D cell expansion in bioreactors, for example to increase the efficiency of the manufacture of stem cells for… Read more »

European project BONE

Eliminating the Need for Repeat Surgery. The Electrospinning Company is part of a European regional consortium led by Maastricht University (UM) which will spend the next four years developing innovative bone implants. These implants will become an alternative for repeat surgeries, prolonged medication use and donor tissue implementation following complex bone fractures. The BONE (Biofabrication… Read more »

Eye on the future

An interview in the Education Times of India with Professor MacNeil describing corneal damage and repair research. In an article published on 31 May 2017, Sheila MacNeil, professor of tissue engineering, department of materials science & engineering, Kroto Research Institute University of Sheffield, UK, speaks to Ruchi Chopda on the status of corneal damage treatment… Read more »

Muscle progenitor stem cells in 3D maintain character after expansion in Mimetix scaffolds

CD133+ progenitor stem cells were shown to maintain ‘stem-ness’ after expansion in Mimetix 3D cell culture. In a recent publication in the Journal of Biomaterials and Tissue Engineering, researchers at KTH in Sweden characterised the growth and differentiation of CD133+ stem cells in Mimetix 3D and in conventional 2D cell culture. CD133+ cells are myogenic progenitors… Read more »

Angel investment secured

The Electrospinning Company Announces £650,000 Investment to Fund Sales Growth and Increase Capacity Harwell, UK — 26 January 2017 — The Electrospinning Company, announces that it has secured a £650,000 investment to establish itself as the leading provider of clinical-grade electrospun biomaterials to the medical device industry. Funding has come from a network of UK… Read more »